UB-311, a novel UBITh^® amyloid β peptide vaccine for mild Alzheimer's disease.

Of note, a subgroup of mild AD patients (Mini–Mental State Examination [MMSE] ≥20) showed a positive trend toward cognition improvement. 2.

also in 11,005 other papers